Issue 10, 2019

BIM-46174 fragments as potential ligands of G proteins

Abstract

The 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine derivative BIM-46174 has received attention as Gαq inhibitor. We conducted structural reductions to monocyclic and bicyclic substructures to explore the chemical space of BIM fragments and to gain insights into the pharmacophore of BIM-type Gαq inhibitors. Two piperazin-2-one-containing fragments and a small library of bicyclic lactams featuring fused pyrazine and diazepine rings were synthesized and evaluated. The results of a second messenger-based cellular assay indicate that the entire BIM structure is required for efficient Gαq inhibition.

Graphical abstract: BIM-46174 fragments as potential ligands of G proteins

Supplementary files

Article information

Article type
Research Article
Submitted
10 May 2019
Accepted
16 Aug 2019
First published
21 Aug 2019

Med. Chem. Commun., 2019,10, 1838-1843

BIM-46174 fragments as potential ligands of G proteins

J. Küppers, T. Benkel, S. Annala, G. Schnakenburg, E. Kostenis and M. Gütschow, Med. Chem. Commun., 2019, 10, 1838 DOI: 10.1039/C9MD00269C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements